Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso...